| Literature DB >> 29913185 |
Qi Tang1, Peng Wu1, Huiqing Chen1, Guohui Li2.
Abstract
Protein ubiquitination is a highly conserved post-translational modification affecting various biological processes including viral propagation. Ubiquitination has multiple effects on viral propagation, including viral genome uncoating, viral replication, and immune evasion. Ubiquitination of viral proteins is triggered by the ubiquitin-proteasome system (UPS). This involves the covalent attachment of the highly conserved 76 amino acid residue ubiquitin protein to target proteins by the consecutive actions of E1, E2 and E3 enzymes, and the 26S proteasome that together form a multiprotein complex that degrades target proteins. The UPS is the primary cytosolic proteolytic machinery for the selective degradation of various forms of proteins including viral proteins, thereby limiting viral growth in host cells. To combat this host anti-viral machinery, viruses have evolved the ability to employ or subvert the UPS to inactivate or degrade cellular proteins to favour viral propagation. This review highlights our current knowledge on the different roles of the UPS during viral propagation.Entities:
Keywords: Disease; Proteolysis; System; Ubiquitin; Ubiquitin-proteasome; Ubiquitination; Viral propagation
Mesh:
Substances:
Year: 2018 PMID: 29913185 PMCID: PMC7094228 DOI: 10.1016/j.lfs.2018.06.014
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037
Fig. 1Degradation of tagged proteins by the ubiquitin-proteasome system (UPS) and the amino acid sequence of ubiquitin (Ub). (A) In this selective proteolytic pathway, Ub is first activated by E1, subsequently transferred to the E2 enzyme, and finally covalently attached to the target substrate. Proteins with polyubiquitin chains are recognised by deubiquitinating enzymes (DUBS) that release Ub, and deubiquitinated proteins are further degraded into small peptides by the 26 proteasome. The 26S proteasome is composed of a 20S catalytic complex and two 19S regulatory complexes. (B) The seven lysine residues in the Ub molecule are coloured red, and their corresponding numbering in the amino acid sequence of Ub is indicated above the red letters. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
The different roles of UPS in viral propagation.
| No. | Virus | Ubiquitinated protein | Ubiquitin acceptor sites/Ub-chain type | Roles of the ubiquitinated proteins in viral propagation | Refs |
|---|---|---|---|---|---|
| 1 | IAV | NP; | Lys184, Lys227, Lys273; | Facilitating viral replication; | [ |
| M2; | Lys78; | Enhancing IAV production; | [ | ||
| PB1 | Lys48 | cellular antiviral defence | [ | ||
| 2 | DENV | NS1 | Lys48 | Regulation of NS1-NS4B interactions | [ |
| 3 | CPXV | 54 viral proteins | Lys(6, 11, 27, 29, 33, 48, 63) | Diverse roles in viral infection | [ |
| 4 | ALV | Intergrase | Thr10, Cys37 | Degradation signal | [ |
| 5 | RSV | Gag | C-terminalglycine of Gag | Viral budding and release | [ |
| 6 | HSV-1 | Capsid | Lys48; | Viral genome release; | [ |
| IκBα | Lys48 (deubiquitination) | Immune evasion | [ | ||
| 7 | Rotavirus | Unknown | Unknown | Enhancing viral replication | [ |
| 8 | HTLV-1 | Tax | Monoubiquitination | Transcriptional regulation | [ |
| 9 | HIV-1 | Tat | Lys(27, 29, 33) | Viral transcription; | [ |
| Gag | Unknown | Viral budding and release | [ | ||
| 10 | HCV | NS2 | Lys63 | Viral envelopment | [ |
| 11 | MCoV | Unknown | Unknown | Viral particle release | [ |
| 12 | HAstV | Unknown | Unknown | Efficient replication | [ |
| 13 | VACV | Unknown | Unknown | Viral replication | [ |
| 14 | TBSV | P33 | Lys70 and Lys76 | Viral replication | [ |
| 15 | HEV | Unknown | Unknown | Viral replication | [ |
| 16 | PCV-2 | Capsid | Unknown | Viral replication | [ |
| 17 | EBOV | VP35 | Lys309 | Viral replication | [ |
| 18 | PRRSV | NEMO | M1 | Immune modulation | [ |
| 19 | EBV | RIPK1/3 | Lys63 | Inhibition of host antiviral defences | [ |
| 20 | HPV | E7 | N-terminal residue of E7 | Inhibitory growth of tumour | [ |
Note: IAV, influenza A virus; DENV, Dengue Virus; CPXV, cowpox virus; ALV, avian leukosis virus; RSV, Rous Sarcoma virus; HSV-1, herpes simplex virus type 1;HTLV-1, human T-cell leukaemia virus 1;HIV-1, human immunodeficiency virus type 1; HCV, hepatitis C virus; MCoV, murine coronavirus; VACV, vaccinia virus; TBSV, tombusvirus; HEV, Hepatitis E virus; PCV-2, porcine circovirus type 2; HAstV, human astrovirus; EBOV, Ebola Virus;EBV, Epstein-Barr virus; PRRSV, porcine reproductive and respiratory syndrome virus;HPV, human papillomavirus.